Ignite Creation Date:
2025-12-25 @ 1:34 AM
Ignite Modification Date:
2026-06-17 @ 7:33 PM
Study NCT ID:
NCT06596694
Status:
RECRUITING
Last Update Posted:
2025-11-18
First Post:
2024-09-11
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of Patritumab Deruxtecan in Participants With Gastrointestinal Cancers (MK-1022-011) (HERTHENA-PanTumor02)
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Gastrointestinal Cancer | View |
Keywords: